7.51
Schlusskurs vom Vortag:
$7.38
Offen:
$7.4
24-Stunden-Volumen:
656.70K
Relative Volume:
0.49
Marktkapitalisierung:
$485.79M
Einnahmen:
$202.09M
Nettoeinkommen (Verlust:
$-61.69M
KGV:
-6.9537
EPS:
-1.08
Netto-Cashflow:
$-35.64M
1W Leistung:
-0.13%
1M Leistung:
-17.56%
6M Leistung:
-47.67%
1J Leistung:
-51.27%
Evolus Inc Stock (EOLS) Company Profile
Firmenname
Evolus Inc
Sektor
Telefon
(949) 284-4555
Adresse
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Vergleichen Sie EOLS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
EOLS
Evolus Inc
|
7.51 | 485.14M | 202.09M | -61.69M | -35.64M | -1.08 |
![]()
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Evolus Inc Stock (EOLS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-06 | Herabstufung | Needham | Buy → Hold |
2025-04-17 | Eingeleitet | BTIG Research | Buy |
2024-01-29 | Hochstufung | Barclays | Equal Weight → Overweight |
2022-06-23 | Eingeleitet | Needham | Buy |
2022-05-12 | Hochstufung | Barclays | Underweight → Equal Weight |
2022-01-20 | Hochstufung | Truist | Hold → Buy |
2021-05-06 | Hochstufung | Mizuho | Neutral → Buy |
2021-04-08 | Bestätigt | H.C. Wainwright | Buy |
2021-02-24 | Herabstufung | Truist | Buy → Hold |
2020-07-07 | Herabstufung | Mizuho | Buy → Neutral |
2020-02-06 | Fortgesetzt | Mizuho | Buy |
2019-11-26 | Eingeleitet | SVB Leerink | Outperform |
2019-09-05 | Fortgesetzt | Mizuho | Buy |
2019-06-28 | Eingeleitet | Wells Fargo | Market Perform |
2019-06-11 | Eingeleitet | Barclays | Underweight |
2019-03-20 | Eingeleitet | SunTrust | Buy |
2019-02-14 | Eingeleitet | H.C. Wainwright | Buy |
2019-01-29 | Eingeleitet | Stifel | Buy |
Alle ansehen
Evolus Inc Aktie (EOLS) Neueste Nachrichten
Is Evolus Inc. a speculative investmentQuarterly Market Summary & Long-Term Growth Plans - khodrobank.com
Has Evolus Inc. formed a bullish divergenceJuly 2025 Closing Moves & Weekly Market Pulse Alerts - Newser
Chart based analysis of Evolus Inc. trendsWeekly Loss Report & Reliable Price Breakout Alerts - Newser
Automated trading signals detected on Evolus Inc.July 2025 Pullbacks & High Accuracy Investment Signals - Newser
Tools to monitor Evolus Inc. recovery probabilityGlobal Markets & Fast Gain Stock Tips - Newser
Is Evolus Inc. stock reversal real or fake2025 Top Gainers & Technical Pattern Based Signals - Newser
Using Bollinger Bands to evaluate Evolus Inc.2025 Top Gainers & Verified Momentum Stock Alerts - Newser
How institutional ownership impacts Evolus Inc. stockTrade Risk Report & AI Driven Stock Reports - Newser
Pattern recognition hints at Evolus Inc. upsideWeekly Gains Summary & Safe Capital Allocation Plans - Newser
How moving averages guide Evolus Inc. tradingGap Down & Comprehensive Market Scan Reports - Newser
Will breakout in Evolus Inc. lead to full recovery2025 Big Picture & Real-Time Price Movement Reports - Newser
Is a relief rally coming for Evolus Inc. holders2025 Trade Ideas & Real-Time Stock Price Movement Reports - Newser
What is Evolus Inc. s 5 year growth outlook getLinesFromResByArray error: size == 0 - mustnews.co.kr
Quantitative breakdown of Evolus Inc. recent moveFed Meeting & Target Return Focused Stock Picks - Newser
Can trapped investors hope for a rebound in Evolus Inc.Market Performance Recap & Fast Gaining Stock Strategy Reports - Newser
Drawdown in Evolus Inc. May Be Nearing End getLinesFromResByArray error: size == 0 - kangso.co.kr
Trendlines Suggest Evolus Inc. May Bottom Out Soon getLinesFromResByArray error: size == 0 - 클래시안
How to interpret RSI for Evolus Inc. stockJuly 2025 News Drivers & Proven Capital Preservation Tips - Newser
Visual analytics tools that track Evolus Inc. performanceBull Run & Smart Allocation Stock Tips - Newser
Understanding Evolus Inc.’s price movementTrend Reversal & Verified Trade Idea Suggestions - Newser
Price action breakdown for Evolus Inc.Trade Analysis Summary & Weekly High Return Stock Opportunities - Newser
Has Evolus Inc. found a price floorJuly 2025 EndofMonth & Safe Entry Trade Reports - Newser
What makes Evolus Inc. stock price move sharplyJuly 2025 Sector Moves & Daily Entry Point Trade Alerts - Newser
Will Evolus Inc. bounce back from current supportChart Signals & Safe Entry Momentum Tips - Newser
What indicators show strength in Evolus Inc.Portfolio Return Report & Technical Confirmation Trade Alerts - Newser
Evolus announces Evolysse Sculpt trial meets primary endpoint - MSN
Analyzing recovery setups for Evolus Inc. investorsJuly 2025 Recap & AI Powered Buy and Sell Recommendations - Newser
Finanzdaten der Evolus Inc-Aktie (EOLS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Evolus Inc-Aktie (EOLS) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Stewart Brady | Director |
Aug 15 '25 |
Buy |
6.82 |
30,000 |
204,486 |
88,629 |
MOATAZEDI DAVID | See Remarks |
Jun 13 '25 |
Sale |
10.05 |
111,323 |
1,119,141 |
381,509 |
MOATAZEDI DAVID | See Remarks |
Jun 16 '25 |
Sale |
9.89 |
16,582 |
164,054 |
364,927 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):